Skip to content

Japan Trial in High-risk Individuals to Accelerate their Referral to Physicians: A Nurse-led, Community-based Prevention Program of Lifestyle-related Disease

Japan Trial in High-risk Individuals to Accelerate their Referral to Physicians: A Nurse-led, Community-based Prevention Program of Lifestyle-related Disease - J-HARP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014012
Enrollment
18400
Registered
2014-05-20
Start date
2014-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, diabetes mellitus, dyslipidemia, and/or chronic kidney disease

Interventions

Heath guidance to encourage clinical visits Conventional health guidance

Sponsors

Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Covered by National Health Insurance 2. Participating in Specific Health Checkups held as the mass screening 3. Meeting at least one of the following criteria: - systolic blood pressure >= 160 mmHg and/or dyastolic blood pressure >= 100 mmHg - Hemoglobin A1c (NGSP) >= 7.0% (if hemoglobin A1c levels are missing, fasting glucose levels >= 130mg/dl; if fasting glucose levels are also missing, casual glucose levels >= 180 mg/dl) - low-density lipoprotein cholesterol levels >= 180 mg/dl in males - Proteinuria >= 2+ 4. Without clinical visits for hypertension, diabetes mellitus, dyslipidemia, and/or proteinurea

Exclusion criteria

Exclusion criteria: Having difficulty in receiving health guidance due to cognitive impairments, other psychiatric disorders, hearing and visual impairments, and other reasons.

Design outcomes

Primary

MeasureTime frame
1. Clinical visit 2. Cumulative incidence of composite outcomes associated with lifestyle-related diseases (the hospitalization related to stroke, myocardial infarction, unstable angina pectoris, heart failure, and dialysis initiation related to chronic renal disease and renal faillure, and deaths from accute cardiac events, cardiovascular disease, chronic renal disease, and renal failure)

Secondary

MeasureTime frame
1. Continued clinical visits 2. Continued participation in Specific Health Checkups 3. Results of health checkups associated with lifestyle-related disease 4. Age at dialysis initiation 5. Annual overall medical expenditure (inpatient and outpatient) per subject 6. Interruption of health guidance

Countries

Japan

Contacts

Public ContactMitsuyoshi Takahara

Osaka University Graduate School of Medicine Metabolic Medicine

takahara@endmet.med.osaka-u.ac.jp06-6879-3743

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026